Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated the efficacy and safety of aliskiren alone and in combination with amlodipine for essential hypertension. The study has completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Aliskiren (Aliskiren)
• Amlodipine (amlodipine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-05-03